vs
Side-by-side financial comparison of Opus Genetics, Inc. (IRD) and KOSS CORP (KOSS). Click either name above to swap in a different company.
Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.9M, roughly 1.4× KOSS CORP). On growth, Opus Genetics, Inc. posted the faster year-over-year revenue change (-10.2% vs -19.6%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs 4.2%).
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
Koss Corporation is a company in Milwaukee, Wisconsin, US that manufactures headphones. The company created the first high-fidelity stereo headphones in 1958.
IRD vs KOSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $2.9M |
| Net Profit | — | $-565.4K |
| Gross Margin | — | 29.0% |
| Operating Margin | — | -35.5% |
| Net Margin | — | -19.8% |
| Revenue YoY | -10.2% | -19.6% |
| Net Profit YoY | 53.0% | -700.6% |
| EPS (diluted) | — | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $2.9M | ||
| Q3 25 | $3.1M | $4.1M | ||
| Q2 25 | $2.9M | $3.1M | ||
| Q1 25 | $4.4M | $2.8M | ||
| Q4 24 | $4.3M | $3.6M | ||
| Q3 24 | $3.9M | $3.2M | ||
| Q2 24 | $1.1M | $2.9M | ||
| Q1 24 | $1.7M | $2.6M |
| Q4 25 | — | $-565.4K | ||
| Q3 25 | $-17.5M | $243.7K | ||
| Q2 25 | $-7.4M | $-232.7K | ||
| Q1 25 | $-8.2M | $-316.7K | ||
| Q4 24 | — | $94.1K | ||
| Q3 24 | $-7.5M | $-419.5K | ||
| Q2 24 | $-7.8M | $-110.4K | ||
| Q1 24 | $-7.1M | $-313.8K |
| Q4 25 | — | 29.0% | ||
| Q3 25 | — | 40.0% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 39.0% | ||
| Q4 24 | — | 39.5% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 40.4% | ||
| Q1 24 | — | 31.9% |
| Q4 25 | — | -35.5% | ||
| Q3 25 | -269.9% | -1.1% | ||
| Q2 25 | -309.0% | -14.2% | ||
| Q1 25 | -227.2% | -18.7% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | -207.1% | -19.9% | ||
| Q2 24 | -748.9% | -11.0% | ||
| Q1 24 | -450.5% | -23.1% |
| Q4 25 | — | -19.8% | ||
| Q3 25 | -566.9% | 6.0% | ||
| Q2 25 | -257.5% | -7.5% | ||
| Q1 25 | -187.5% | -11.4% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | -194.6% | -13.1% | ||
| Q2 24 | -698.3% | -3.8% | ||
| Q1 24 | -415.3% | -11.9% |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | $-0.25 | $0.03 | ||
| Q2 25 | $-0.12 | $-0.02 | ||
| Q1 25 | $-0.24 | $-0.03 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-0.29 | $-0.05 | ||
| Q2 24 | $-0.30 | $-0.01 | ||
| Q1 24 | $-0.29 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $45.1M | $15.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.3M | $30.3M |
| Total Assets | $50.2M | $36.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.1M | $15.5M | ||
| Q3 25 | $30.8M | $16.5M | ||
| Q2 25 | $32.4M | $15.7M | ||
| Q1 25 | $41.8M | $13.0M | ||
| Q4 24 | $30.3M | $9.7M | ||
| Q3 24 | $36.6M | $11.9M | ||
| Q2 24 | $41.4M | $14.9M | ||
| Q1 24 | $47.2M | $9.9M |
| Q4 25 | $15.3M | $30.3M | ||
| Q3 25 | $6.0M | $30.9M | ||
| Q2 25 | $17.5M | $30.6M | ||
| Q1 25 | $5.1M | $30.7M | ||
| Q4 24 | $6.7M | $31.0M | ||
| Q3 24 | $34.3M | $30.8M | ||
| Q2 24 | $40.6M | $31.1M | ||
| Q1 24 | $46.1M | $31.1M |
| Q4 25 | $50.2M | $36.8M | ||
| Q3 25 | $36.1M | $37.7M | ||
| Q2 25 | $38.7M | $37.2M | ||
| Q1 25 | $48.2M | $37.3M | ||
| Q4 24 | $36.9M | $37.4M | ||
| Q3 24 | $40.4M | $38.1M | ||
| Q2 24 | $44.8M | $37.2M | ||
| Q1 24 | $51.8M | $37.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-35.3M | $-760.8K |
| Free Cash FlowOCF − Capex | — | $-1.1M |
| FCF MarginFCF / Revenue | — | -37.5% |
| Capex IntensityCapex / Revenue | — | 10.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-546.7K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-35.3M | $-760.8K | ||
| Q3 25 | $-6.2M | $762.6K | ||
| Q2 25 | $-10.3M | $-534.9K | ||
| Q1 25 | $-9.0M | $370.4K | ||
| Q4 24 | $-25.6M | $-252.0K | ||
| Q3 24 | $-5.1M | $201.6K | ||
| Q2 24 | $-7.3M | $-174.0K | ||
| Q1 24 | $-5.7M | $328.6K |
| Q4 25 | — | $-1.1M | ||
| Q3 25 | — | $761.5K | ||
| Q2 25 | — | $-541.8K | ||
| Q1 25 | — | $306.2K | ||
| Q4 24 | — | $-314.3K | ||
| Q3 24 | — | $-155.6K | ||
| Q2 24 | — | $-174.8K | ||
| Q1 24 | — | $269.3K |
| Q4 25 | — | -37.5% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | — | -17.6% | ||
| Q1 25 | — | 11.0% | ||
| Q4 24 | — | -8.8% | ||
| Q3 24 | — | -4.9% | ||
| Q2 24 | — | -6.0% | ||
| Q1 24 | — | 10.2% |
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.13× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.68× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
